Morgan Stanley lowered the firm’s price target on Aperam (APEMY) to EUR 28.60 from EUR 29.60 and keeps an Equal Weight rating on the shares. Stainless earnings “remain lackluster,” says the analyst, who lowers 2025 estimates.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY: